BJP Try Advances in Psychiatric Treatment Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomson, R.

The British Journal of Psychiatry 140: 64-68 (1982)
© 1982 The Royal College of Psychiatrists

Side effects and placebo amplification

R Thomson

A sample of placebo-controlled tricyclic antidepressant studies was examined retrospectively to determine whether there was any difference in the relative efficacy of the tricyclic when it was compared against an inert placebo as against an active (atropine) placebo with anticholinergic side effects. Fewer studies showed a significant difference between atropine placebo and drug than between inert placebo and drug. The possibilities that atropine has a specific antidepressant effect, or that side effects amplify placebo responses are considered.


This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
J. MONCRIEFF
The antidepressant debate
The British Journal of Psychiatry, March 1, 2002; 180(3): 193 - 194.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
C. EVEN, E. SIOBUD-DOROCANT, and R. M. DARDENNES
Critical approach to antidepressant trials: Blindness protection is necessary, feasible and measurable
The British Journal of Psychiatry, July 1, 2000; 177(1): 47 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
F. M. Quitkin, J. G. Rabkin, J. Gerald, J. M. Davis, and D. F. Klein
Validity of Clinical Trials of Antidepressants
Am J Psychiatry, March 1, 2000; 157(3): 327 - 337.
[Abstract] [Full Text]

Home page
 Am. J. PsychiatryHome page
F. M. Quitkin
Placebos, Drug Effects, and Study Design: A Clinician's Guide
Am J Psychiatry, June 1, 1999; 156(6): 829 - 836.
[Abstract] [Full Text]

Home page
 JAMAHome page
J. C. Shlay, K. Chaloner, M. B. Max, B. Flaws, P. Reichelderfer, D. Wentworth, S. Hillman, B. Brizz, D. L. Cohn, and for the Terry Beirn Community Programs for Clinica
Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral Neuropathy: A Randomized Controlled Trial
JAMA, November 11, 1998; 280(18): 1590 - 1595.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1982 The Royal College of Psychiatrists.